Allergan executive moves to CEO role at Hospira
LAKE FOREST, Ill. — Generic drug maker Hospira has appointed Mike Ball as CEO, effective March 28, the company said. Ball currently is president of Allergan.
Ball, who also was appointed to the company’s board, will replace Christopher Begley, who will assume the role of executive chairman.
“From the outset of our CEO search, the board and I were determined to identify a candidate who would extend Hospira’s growth trajectory, expand our global reach and inspire our employees as we continue our patient-focused journey to sustainable top-tier financial performance,” Begley said. “With his proven track record of growing complex global businesses, demonstrated success in leading diversified healthcare portfolios and strong commitment to creating value for all company stakeholders, we found the perfect fit with Mike Ball.”
New diabetes drug accepted for review by FDA
PRINCETON, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.
The FDA accepted the application for dapagliflozin, an investigational drug for adults with the disease. The Centers for Disease Control and Prevention estimated that 1-in-11 U.S. adults has diabetes, with 90% to 95% of them having Type 2 diabetes.
The agency expects to take action on the application in late October.
Walmart exec elected chair of health, benefits group
SAN FRANCISCO — Walmart’s U.S. VP benefits, Chris McSwain, was elected chairman of the Integrated Benefits Institute, the organization announced Monday.
“Chris McSwain has played an important leadership role in the health benefits community, and we look forward to his continued leadership with IBI,” said Thomas Parry, president of the nonprofit health and productivity research organization.
“The work done by IBI has played a critical role in helping employers and their supplier partners work more effectively to manage work force health and productivity,” McSwain said. “U.S. employers face both challenges and opportunities as we navigate health reform, and I’m excited to be working with IBI at this critical time.”
Others elected to leadership roles at the organization include Dan Lyon, VP and manager for Liberty Mutual, who was elected vice chair, and Anita Weir, manager of health services for Safeway, who was elected treasurer.
IBI provides employers and their supplier partners with resources for demonstrating the business value of health. As a pioneer, leader and nonprofit supplier of health and productivity research, measurement and benchmarking, IBI is a source for benefits performance analysis, research-based approaches and forums for information and education. IBI’s programs, resources and expert member networks advance understanding about the link between and the impact of health-related productivity on corporate America’s bottom line.